E-LIB Suche - Ergebnisse für: Hartenfeller, Markus

1

Consolidated BRCA1/2 Variant Interpretation by MH BRCA Corr..:

Hirotsu, Yosuke ; Schmidt-Edelkraut, Udo ; Nakagomi, Hiroshi...
International Journal of Molecular Sciences. 21 (2020) 11 - p. 3895 , 2020

Link: https://doi.org/10.3390/..

2

Repurposing de novo designed entities reveals phosphodieste..:

Rodrigues, Tiago ; Lin, Yen-Chu ; Hartenfeller, Markus...
Chemical Communications. 51 (2015) 35 - p. 7478-7481 , 2015

Link: https://doi.org/10.1039/..

3

Wirkstoffe nach Zahlen: reaktionsbasierter De-novo-Entwurf ..:

Spänkuch, Birgit ; Keppner, Sarah ; Lange, Lisa...
Angewandte Chemie. 125 (2012) 17 - p. 4774-4779 , 2012

Link: https://doi.org/10.1002/..

4

Drugs by Numbers: Reaction‐Driven De Novo Design of Potent ..:

Spänkuch, Birgit ; Keppner, Sarah ; Lange, Lisa...
Angewandte Chemie International Edition. 52 (2012) 17 - p. 4676-4681 , 2012

Link: https://doi.org/10.1002/..

5

Probing the Bioactivity-Relevant Chemical Space of Robust R..:

Hartenfeller, Markus ; Eberle, Martin ; Meier, Peter...
Journal of Chemical Information and Modeling. 52 (2012) 5 - p. 1167-1178 , 2012

Link: https://doi.org/10.1021/..

6

DOGS: Reaction-Driven de novo Design of Bioactive Compounds:

Hartenfeller, Markus ; Zettl, Heiko ; Walter, Miriam...
PLoS Computational Biology. 8 (2012) 2 - p. e1002380 , 2012

Link: https://doi.org/10.1371/..

7

Enabling future drug discovery by de novo design:

Hartenfeller, Markus ; Schneider, Gisbert
WIREs Computational Molecular Science. 1 (2011) 5 - p. 742-759 , 2011

Link: https://doi.org/10.1002/..

8

A Collection of Robust Organic Synthesis Reactions for In S..:

Hartenfeller, Markus ; Eberle, Martin ; Meier, Peter...
Journal of Chemical Information and Modeling. 51 (2011) 12 - p. 3093-3098 , 2011

Link: https://doi.org/10.1021/..

9

Multistep Virtual Screening for Rapid and Efficient Identif..:

Zander, Johannes ; Hartenfeller, Markus ; Hähnke, Volker...
Chemistry - A European Journal. 16 (2010) 31 - p. 9630-9637 , 2010

Link: https://doi.org/10.1002/..

10

'Fuzziness' in pharmacophore-based virtual screening and de..:

Klenner, Alexander ; Hartenfeller, Markus ; Schneider, Petra.
Drug Discovery Today: Technologies. 7 (2010) 4 - p. e237-e244 , 2010

Link: https://doi.org/10.1016/..

11

Voyages to the (un)known: adaptive design of bioactive comp..:

Schneider, Gisbert ; Hartenfeller, Markus ; Reutlinger, Michael...
Trends in Biotechnology. 27 (2009) 1 - p. 18-26 , 2009

Link: https://doi.org/10.1016/..

12

Concept of Combinatorial De Novo Design of Drug‐like Molecu..:

Hartenfeller, Markus ; Proschak, Ewgenij ; Schüller, Andreas.
Chemical Biology & Drug Design. 72 (2008) 1 - p. 16-26 , 2008

Link: https://doi.org/10.1111/..

13

Repurposing de novo designed entities reveals phosphodieste..:

Rodrigues, Tiago ; Lin, Yen-Chu ; Hartenfeller, Markus...
info:eu-repo/semantics/altIdentifier/doi/10.1039/c5cc01376c. , 2015

Link: https://hdl.handle.net/2..

14

DOGS: Reaction-Driven de novo Design of Bioactive Compounds:

Schneider, Gisbert ; Hartenfeller, Markus ; Zettl, Heiko...
info:eu-repo/semantics/altIdentifier/doi/10.1371/journal.pcbi.1002380. , 2012

Link: https://hdl.handle.net/2..

15

DOGS: reaction-driven de novo design of bioactive compounds:

Hartenfeller, Markus ; Zettl, Heiko ; Walter, Miriam...
http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/24617. , 2012

Link: http://publikationen.ub...